Alvogen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALVOGEN
ALVOGEN has fifty-four approved drugs.
There are two tentative approvals on ALVOGEN drugs.
Summary for Alvogen
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 42 |
| NDAs: | 54 |
| Patent Litigation for Alvogen: | See patent lawsuits for Alvogen |
| PTAB Cases with Alvogen as petitioner: | See PTAB cases with Alvogen as petitioner |
Drugs and US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 076830-001 | Aug 31, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen Pine Brook | BOSENTAN | bosentan | TABLET;ORAL | 206002-001 | Apr 26, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | HYDROCODONE BITARTRATE | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 206986-002 | Jan 21, 2020 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | HYDROCODONE BITARTRATE | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 206986-004 | Jan 21, 2020 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-004 | Aug 1, 1984 | 4,012,444 | ⤷ Start Trial |
| Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | 7,026,337 | ⤷ Start Trial |
| Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-002 | Aug 1, 1984 | 4,066,755 | ⤷ Start Trial |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-002 | Oct 31, 1985 | 4,642,384 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
